» Articles » PMID: 12559174

The RAG-1/2 Endonuclease Causes Genomic Instability and Controls CNS Complications of Lymphoblastic Leukemia in P53/Prkdc-deficient Mice

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2003 Feb 1
PMID 12559174
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Double-strand DNA breaks (DSB) induce chromosomal translocations and gene amplification in cell culture, but mechanisms by which DSB cause genomic instability in vivo are poorly understood. We show that RAG-1/2-induced DSB cause IgH/c-Myc translocations in leukemic pro-B cells from p53/Prkdc-deficient mice. Strikingly, these translocations were complex, clonally heterogeneous and amplified. We observed reiterated IgH/c-Myc fusions on dicentric chromosomes, suggesting that amplification occurred by repeated cycles of bridge, breakage and fusion. Leukemogenesis was not mitigated in RAG-2/p53/Prkdc-deficient mice, but leukemic pro-B cells lacked IgH/c-Myc translocations. Thus, global genomic instability conferred by p53/Prkdc disruption efficiently transforms pro-B cells lacking RAG-1/2-induced DSB. Unexpectedly, RAG-2/p53/Prkdc-deficient mice also developed leptomeningeal leukemia, providing a novel spontaneous model for this frequent complication of human lymphoblastic malignancies.

Citing Articles

The recombinase activating genes: architects of immune diversity during lymphocyte development.

Braams M, Pike-Overzet K, Staal F Front Immunol. 2023; 14:1210818.

PMID: 37497222 PMC: 10367010. DOI: 10.3389/fimmu.2023.1210818.


Direct regulation of TCR rearrangement and expression by E proteins during early T cell development.

Anderson M, da Rocha J WIREs Mech Dis. 2022; 14(6):e1578.

PMID: 35848146 PMC: 9669112. DOI: 10.1002/wsbm.1578.


Targeted blockade of immune mechanisms inhibit B precursor acute lymphoblastic leukemia cell invasion of the central nervous system.

Rajakumar S, Grandal I, Minden M, Hitzler J, Guidos C, Danska J Cell Rep Med. 2022; 2(12):100470.

PMID: 35028611 PMC: 8714910. DOI: 10.1016/j.xcrm.2021.100470.


B7-H6 is a new potential biomarker and therapeutic target of T-lymphoblastic lymphoma.

Yuan L, Sun L, Yang S, Chen X, Wang J, Jing H Ann Transl Med. 2021; 9(4):328.

PMID: 33708955 PMC: 7944329. DOI: 10.21037/atm-20-5308.


Bad to the bone: B cell acute lymphoblastic leukemia cells mediate bone destruction.

Rajakumar S, Danska J Mol Cell Oncol. 2021; 8(1):1835423.

PMID: 33553597 PMC: 7849691. DOI: 10.1080/23723556.2020.1835423.